MyAverix Finance MyAverix Finance

BE · Other

BIOMARIN PHARM (BM8)

Diversified

BIOMARIN PHARM (BM8) is listed on BE in the Other sector. Industry: Diversified. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-22

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for BM8

P/E ratio
18.00

BIOMARIN PHARM (BM8) — FAQ

What is BM8's P/E ratio?

The price-to-earnings (P/E) ratio for BIOMARIN PHARM (BM8) is 18.00 (data as of 2026-03-22).

Does BIOMARIN PHARM pay a dividend?

Dividend yield is not available in the current snapshot for BIOMARIN PHARM (BM8). Check the MyAverix Finance app for the latest dividend data.

What sector is BIOMARIN PHARM in?

BIOMARIN PHARM (BM8) is classified in the Other sector (Diversified industry).

What exchange is BM8 listed on?

BM8 is listed on BE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Other companies

Apple Inc (APC) Microsoft Corporation (MSF)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play